Semler Scientific, Inc. (NASDAQ:SMLR) Holdings Boosted by Shariaportfolio Inc.

Shariaportfolio Inc. increased its holdings in Semler Scientific, Inc. (NASDAQ:SMLRFree Report) by 4.5% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 160,453 shares of the company’s stock after acquiring an additional 6,837 shares during the quarter. Semler Scientific accounts for 4.1% of Shariaportfolio Inc.’s portfolio, making the stock its 7th largest position. Shariaportfolio Inc.’s holdings in Semler Scientific were worth $8,664,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Cerity Partners LLC lifted its holdings in Semler Scientific by 91.5% during the third quarter. Cerity Partners LLC now owns 1,345,586 shares of the company’s stock valued at $31,689,000 after purchasing an additional 642,982 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in Semler Scientific by 633.1% during the fourth quarter. Principal Financial Group Inc. now owns 112,487 shares of the company’s stock valued at $6,074,000 after purchasing an additional 97,144 shares in the last quarter. Exchange Traded Concepts LLC lifted its holdings in Semler Scientific by 345.8% during the fourth quarter. Exchange Traded Concepts LLC now owns 61,396 shares of the company’s stock valued at $3,315,000 after purchasing an additional 47,625 shares in the last quarter. Deltec Asset Management LLC purchased a new position in Semler Scientific during the fourth quarter valued at approximately $2,462,000. Finally, Crawford Fund Management LLC purchased a new position in Semler Scientific during the third quarter valued at approximately $883,000. Hedge funds and other institutional investors own 49.37% of the company’s stock.

Semler Scientific Price Performance

Shares of NASDAQ:SMLR opened at $47.74 on Monday. Semler Scientific, Inc. has a 1-year low of $20.88 and a 1-year high of $81.56. The firm’s 50 day simple moving average is $56.42 and its two-hundred day simple moving average is $42.95. The company has a market capitalization of $442.55 million, a P/E ratio of 9.72 and a beta of 1.17.

Semler Scientific (NASDAQ:SMLRGet Free Report) last released its earnings results on Tuesday, February 18th. The company reported $3.41 EPS for the quarter, topping the consensus estimate of $0.20 by $3.21. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%. The firm had revenue of $12.41 million for the quarter.

Analysts Set New Price Targets

Separately, Lake Street Capital lifted their price target on shares of Semler Scientific from $40.00 to $71.00 and gave the company a “buy” rating in a report on Friday, January 24th.

Check Out Our Latest Analysis on Semler Scientific

Semler Scientific Profile

(Free Report)

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.

Featured Articles

Want to see what other hedge funds are holding SMLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Semler Scientific, Inc. (NASDAQ:SMLRFree Report).

Institutional Ownership by Quarter for Semler Scientific (NASDAQ:SMLR)

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.